Radiological and Nuclear Emergency: Medical Management and Dosimetry – REMEDY
The REMEDY training course is organised by the Federal Office for Radiation Protection (BfS) and supported by the Charité - Universitätsmedizin Berlin within the framework of the European Partnership for Radiation Protection Research “PIANOFORTE“.
The REMEDY course gives an overview of (pre-)clinical and medical management procedures and introduces different dosimetry methods that can be used for individual dose assessment in the event of a radiological or nuclear emergency. The aim is to highlight the need for closer collaboration and complementary use of medical interventions and dosimetry techniques to ensure state-of-the-art management of exposed individuals and to handle large numbers of affected persons as well.
Course content
The course is divided into lectures, demonstrations and exercises. The entire course lasts five days (Monday lunch - Friday afternoon).
(Pre-)clinical and medical management
An overview will be given of the basics of decontamination, radiation protection for clinical staff and strategies to avoid cross-contamination in the hospital setting. These topics will be demonstrated and participants will have the opportunity to improve their knowledge through hands-on exercises. Further theoretical insight will be provided in the areas of decorporation and medical treatment.
Dosimetry
Different dosimetry methods will be introduced: clinical dosimetry, internal dosimetry, biological dosimetry and retrospective physical dosimetry. The basics of the methods, their application, advantages and limitations will be discussed.
Associated topics
A refresher on the basic physical, biological and medical principles of the effects of ionising radiation will be provided. In addition, related topics such as special exposure situations due to major incidents, disaster management, and the behaviour and communication of affected individuals will be covered.
General information
Audience
The course is open to physicians, authority staff and scientists at all career levels from the European Union and associated countries. Course participants should be interested — or already involved — in the course topics and wish to broaden their knowledge in the field of medical management and dosimetry in radiological or nuclear emergencies.
To be able to follow the course content properly, basic knowledge of radiation protection and
ionising radiation is recommended. However, the basic physical, biological and medical
principles of the effects of ionising radiation are refreshed at the beginning of the course to
provide a common baseline. Maximum number of participants: 20
Venue
The course takes place at the Federal Office for Radiation Protection in Berlin: Bundesamt für Strahlenschutz (BfS)
Köpenicker Allee 120, 10318 Berlin
Costs & accommodation
Thanks to the financial support of PIANOFORTE, the course is free of charge. Participants are responsible for their own travel costs (travel, accommodation, meals and other expenses). However, you may consider applying for a PIANOFORTE travel grant for early career professional and researchers.
The place of your stay is at your discretion. The following hotels are located nearby:
Abacus Tierpark Hotel Franz-Mett-Straße 3-9 10319 Berlin
Allee-Hotel Berlin Köpenicker Allee 60-62 10318 Berlin
Organisational details
A certificate of attendance will be issued to all participants. However, no ECTS credits will be awarded.
For a biological dosimetry exercise, you will need to bring your own laptop or tablet (a mobile phone is not sufficient).
Application
The deadline for applications is 14 September 2025.
You will receive feedback by 19 September.
Applications should contain:
• letter of motivation (200-300 words)
• structured, short CV
Please email your application to remedy-training@bfs.de
For more information please contact:Dr. Martin BUCHER
Federal Office for Radiation Protection Biological Dosimetry Section ? WR2 remedy-training@bfs.de
This course is funded by PIANOFORTE research partnership. PIANOFORTE partnership has received funding from the European Union’s “EURATOM” research and innovation program under the 101061037 grant agreement.